Metacare Becomes Largest Shareholder of Techlabs... Expands Hair Loss Medical Business by Combining AI and Digital Healthcare

Metacare is strengthening its business competitiveness by acquiring the position of largest shareholder in Techlabs, an artificial intelligence (AI)-based adtech and digital healthcare platform company.

On June 29, Metacare announced that it had acquired additional shares in Techlabs, bringing its total ownership to 47.51%. With this acquisition, Techlabs will be incorporated as a consolidated subsidiary of Metacare. The company expects that, by reflecting Techlabs’ results on a consolidated basis, it will be able to expand its business scale and strengthen its profit base.

This investment is a follow-up strategy to Metacare’s paid-in capital increase, which was disclosed on June 10. At that time, Metacare decided on a third-party allotment capital increase of 6 billion won, targeting its largest shareholder, Metalabs, to secure funds for business expansion.

Techlabs operates an adtech business that analyzes customer data and improves marketing efficiency using AI, big data, and software-as-a-service (SaaS) technology. In particular, it possesses digital marketing capabilities that support the entire process for clinics and hospitals in the aesthetic medical field, from customer acquisition and consultation conversion to sales growth. The company is also developing and operating platforms in healthcare areas such as hair loss and hair transplantation.

Metacare’s main business has been supplying healthcare products such as pharmaceuticals, medical devices, and medical consumables to healthcare institutions. The company plans to enhance its business competitiveness by combining its existing network of medical institutions with Techlabs’ AI-based data analysis, digital marketing, and platform operation capabilities, following this share acquisition.

In particular, Metacare aims to expand synergy in the hair loss healthcare sector, in collaboration with its parent company, Metalabs. Amid growing interest in the related medical market due to recent discussions about including hair loss medication in health insurance, the company plans to strengthen the hair loss medical value chain by combining Momolabs’ foundation in hair loss and hair transplantation businesses with Techlabs’ data analysis and marketing optimization technology, covering all stages from customer acquisition and consultation to procedures and follow-up care.

Through these efforts, Metacare intends to establish a new business model that combines hair loss healthcare and digital platform technology, and to secure mid- to long-term growth drivers.

A Metacare official stated, “This acquisition of shares in Techlabs is a strategic investment to incorporate AI adtech and digital healthcare platform capabilities into our existing business structure, which has been centered on medical distribution. We expect that reflecting Techlabs’ results on a consolidated basis will make a meaningful contribution to expanding both the scale and profit base of our business.”

Meanwhile, in the first quarter of this year, Metacare recorded consolidated sales of 10.1 billion won and operating profit of 600 million won. Techlabs achieved sales of 92.3 billion won and operating profit of 7.4 billion won in 2025.

With the acquisition of Techlabs, Metacare is accelerating the expansion of its healthcare business, combining its medical distribution capabilities with AI-based digital platform technology, with a focus on the hair loss medical market.

This content was produced with the assistance of AI translation services.